On the public citation graph
Structure–Activity Relationship Studies of Pyrazolo[3,4-d]pyrimidine Derivatives Leading to the Discovery of a Novel Multikinase Inhibitor That Potently Inhibits FLT3 and VEGFR2 and Evaluation of Its Activity against Acute Myeloid Leukemia in Vitro and in Vivo
0 signed · 110 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/path.2319openalex-snapshot
Hypoxia‐inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte–osteoclast differentiation via induction of VEGF
inferredcites →https://doi.org/10.1007/s00018-012-1085-3openalex-snapshot
Vascular endothelial growth factor signaling in acute myeloid leukemia
inferredcites →https://doi.org/10.1007/s12253-012-9495-yopenalex-snapshot
Angiogenesis and Survival in Patients with Myelodysplastic Syndrome
inferredcites →https://doi.org/10.1016/j.bbrc.2007.04.033openalex-snapshot
A critical role of vascular endothelial growth factor D in zebrafish embryonic vasculogenesis and angiogenesis
inferredcites →https://doi.org/10.1016/j.ejmech.2012.08.007openalex-snapshot
Discovery of N6-phenyl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamine derivatives as novel CK1 inhibitors using common-feature pharmacophore model based virtual screening and hit-to-lead optimization
inferredcites →https://doi.org/10.1021/jm030427ropenalex-snapshot
Novel Potent Orally Active Selective VEGFR-2 Tyrosine Kinase Inhibitors: Synthesis, Structure−Activity Relationships, and Antitumor Activities of N-Phenyl-N‘-{4-(4-quinolyloxy)phenyl}ureas
inferredcites →https://doi.org/10.1021/jm100189aopenalex-snapshot
Toward the Development of Innovative Bifunctional Agents To Induce Differentiation and To Promote Apoptosis in Leukemia: Clinical Candidates and Perspectives
inferredcites →https://doi.org/10.1021/jm200712hopenalex-snapshot
Design, Synthesis, and Evaluation of a Novel Dual Fms-Like Tyrosine Kinase 3/Stem Cell Factor Receptor (FLT3/c-KIT) Inhibitor for the Treatment of Acute Myelogenous Leukemia
inferredcites →https://doi.org/10.1021/jm2013453openalex-snapshot
Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors
inferredcites →https://doi.org/10.1021/jm300042xopenalex-snapshot
Discovery of the Novel Potent and Selective FLT3 Inhibitor 1-{5-[7-(3- Morpholinopropoxy)quinazolin-4-ylthio]-[1,3,4]thiadiazol-2-yl}-3-p-tolylurea and Its Anti-Acute Myeloid Leukemia (AML) Activities in Vitro and in Vivo
inferredcites →https://doi.org/10.1021/jm300952sopenalex-snapshot
Optimization of Imidazo[4,5-b]pyridine-Based Kinase Inhibitors: Identification of a Dual FLT3/Aurora Kinase Inhibitor as an Orally Bioavailable Preclinical Development Candidate for the Treatment of Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1021/jm9007533openalex-snapshot
Identification of N-(5-tert-Butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea Dihydrochloride (AC220), a Uniquely Potent, Selective, and Efficacious FMS-Like Tyrosine Kinase-3 (FLT3) Inhibitor
inferredcites →https://doi.org/10.1021/jm901509aopenalex-snapshot
BRAF Inhibitors Based on an Imidazo[4,5]pyridin-2-one Scaffold and a Meta Substituted Middle Ring
inferredcites →https://doi.org/10.1038/leu.2012.105openalex-snapshot
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
inferredcites →https://doi.org/10.1038/leu.2012.67openalex-snapshot
SKLB1028, a novel oral multikinase inhibitor of EGFR, FLT3 and Abl, displays exceptional activity in models of FLT3-driven AML and considerable potency in models of CML harboring Abl mutants
inferredcites →https://doi.org/10.1038/nature11016openalex-snapshot
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
inferredcites →https://doi.org/10.1038/sj.leu.2402534openalex-snapshot
Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia
inferredcites →https://doi.org/10.1038/sj.leu.2402740openalex-snapshot
FLT3 mutations in acute myeloid leukemia cell lines
inferredcites →https://doi.org/10.1056/nejmoa074306openalex-snapshot
Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1074/jbc.m708055200openalex-snapshot
VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
inferredcites →https://doi.org/10.1111/j.1600-0609.2004.00225.xopenalex-snapshot
Clinical impact of internal tandem duplications and activating point mutations in FLT3 in acute myeloid leukemia in elderly patients
inferredcites →https://doi.org/10.1155/2012/128608openalex-snapshot
Angiogenesis in Acute Myeloid Leukemia and Opportunities for Novel Therapies
inferredcites →https://doi.org/10.1158/0008-5472.can-07-3126openalex-snapshot
Automated, Quantitative Screening Assay for Antiangiogenic Compounds Using Transgenic Zebrafish
inferredcites →https://doi.org/10.1158/0008-5472.can-10-0402openalex-snapshot
Repression of Vascular Endothelial Growth Factor Expression by the Runt-Related Transcription Factor 1 in Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1158/1078-0432.ccr-05-0358openalex-snapshot
CHIR-258: A Potent Inhibitor of FLT3 Kinase in Experimental Tumor Xenograft Models of Human Acute Myelogenous Leukemia
inferredcites →https://doi.org/10.1158/1078-0432.ccr-10-3109openalex-snapshot
SKLB1002, a Novel Potent Inhibitor of VEGF Receptor 2 Signaling, Inhibits Angiogenesis and Tumor Growth In Vivo
inferredcites →https://doi.org/10.1182/blood-2002-02-0492openalex-snapshot
The roles of FLT3 in hematopoiesis and leukemia
inferredcites →https://doi.org/10.1182/blood-2002-07-2307openalex-snapshot
SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo
inferredcites →https://doi.org/10.1182/blood-2003-11-3775openalex-snapshot
Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia
inferredcites →https://doi.org/10.1182/blood-2006-02-005702openalex-snapshot
Phase 1 clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics
inferredcites →https://doi.org/10.1182/blood-2006-03-009233openalex-snapshot
Clinical implications of FLT3 mutations in pediatric AML
inferredcites →https://doi.org/10.1182/blood-2007-05-092510openalex-snapshot
Internal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML
inferredcites →https://doi.org/10.1182/blood-2007-06-097253openalex-snapshot
RNAi screening of the tyrosine kinome identifies therapeutic targets in acute myeloid leukemia
inferredcites →https://doi.org/10.1182/blood-2007-07-101394openalex-snapshot
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
inferredcites →https://doi.org/10.1182/blood-2009-05-222034openalex-snapshot
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
inferredcites →https://doi.org/10.1182/blood.v89.6.1870openalex-snapshot
Vascular Endothelial Growth Factor, a Possible Paracrine Growth Factor in Human Acute Myeloid Leukemia
inferredcites →https://doi.org/10.1182/blood.v98.6.1752openalex-snapshot
The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the United Kingdom Medical Research Council AML 10 and 12…
inferredcites →https://doi.org/10.1182/blood.v99.12.4326openalex-snapshot
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
inferredcites →https://doi.org/10.1210/en.143.4.1545openalex-snapshot
Bone Morphogenetic Proteins Stimulate Angiogenesis through Osteoblast-Derived Vascular Endothelial Growth Factor A
inferredcites →https://doi.org/10.1359/jbmr.0301229openalex-snapshot
Estrogen Regulates the Production of VEGF for Osteoclast Formation and Activity in op/op Mice
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4679402openalex-extracted
Styryl Carbamates Backbones for the Discovery of TME-Disruptors Agents
inferred← citeshttps://doi.org/10.1002/ardp.201900319openalex-snapshot
Novel pyrazolopyrimidine urea derivatives: Synthesis, antiproliferative activity, VEGFR‐2 inhibition, and effects on the cell cycle profile
inferred← citeshttps://doi.org/10.1002/ardp.202200424openalex-snapshot
Pyrazolo[3,4‐d]pyrimidine scaffold: A review on synthetic approaches and EGFR and VEGFR inhibitory activities
inferred← citeshttps://doi.org/10.1002/cmdc.202000658openalex-snapshot
Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
inferred← citeshttps://doi.org/10.1002/ejoc.201701693openalex-snapshot
Total Synthesis and Evaluation of B‐Homo Palmatine and Berberine Derivatives as p300 Histone Acetyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1002/hep4.1181openalex-snapshot
Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival
inferred← citeshttps://doi.org/10.1007/s00044-016-1667-yopenalex-snapshot
Design, synthesis, and cytostatic activity of novel pyrazine sorafenib analogs
inferred← citeshttps://doi.org/10.1007/s00044-024-03259-3openalex-snapshot
Docking-guided exploration of the anti-flt3 potential of isoindigo derivatives towards potential treatments of acute myeloid leukemia
inferred← citeshttps://doi.org/10.1007/s12272-018-1050-2openalex-snapshot
Synthesis and structure–activity relationship of N-(piperidin-4-yl)benzamide derivatives as activators of hypoxia-inducible factor 1 pathways
inferred← citeshttps://doi.org/10.1016/j.arabjc.2022.104110openalex-snapshot
Synthesis, bioactivity and preliminary mechanism of action of novel trifluoromethyl pyrimidine derivatives
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.12.015openalex-snapshot
Zebrafish disease models in hematology: Highlights on biological and translational impact
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.09.001openalex-snapshot
Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling
inferred← citeshttps://doi.org/10.1016/j.bioorg.2018.10.008openalex-snapshot
Design, synthesis and molecular modeling study of certain VEGFR-2 inhibitors based on thienopyrimidne scaffold as cancer targeting agents
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104518openalex-snapshot
Synthesis of N-2(5H)-furanonyl sulfonyl hydrazone derivatives and their biological evaluation in vitro and in vivo activity against MCF-7 breast cancer cells
inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.104527openalex-snapshot
Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105019openalex-snapshot
Discovery of potent thieno[2,3-d]pyrimidine VEGFR-2 inhibitors: Design, synthesis and enzyme inhibitory evaluation supported by molecular dynamics simulations
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105350openalex-snapshot
Double-edged Swords: Diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis
inferred← citeshttps://doi.org/10.1016/j.bioorg.2023.106425openalex-snapshot
Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.12.038openalex-snapshot
Expanding the structural diversity of diarylureas as multi-target tyrosine kinase inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2019.03.049openalex-snapshot
Discovery of thiazolidin-4-one urea analogues as novel multikinase inhibitors that potently inhibit FLT3 and VEGFR2
inferred← citeshttps://doi.org/10.1016/j.ejmech.2015.02.019openalex-snapshot
LEADOPT: An automatic tool for structure-based lead optimization, and its application in structural optimizations of VEGFR2 and SYK inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2016.02.029openalex-snapshot
Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: Design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives
inferred← citeshttps://doi.org/10.1016/j.ejmech.2017.04.010openalex-snapshot
Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)- N -phenylacetamide derivatives as new potent and selective human sirtuin 2 inhibitors
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.01.032openalex-snapshot
((S)-3-Mercapto-2-methylpropanamido)acetic acid derivatives as metallo-β-lactamase inhibitors: Synthesis, kinetic and crystallographic studies
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.01.058openalex-snapshot
Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents
inferred← citeshttps://doi.org/10.1016/j.ejmech.2018.06.041openalex-snapshot
X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells
inferred← citeshttps://doi.org/10.1016/j.ejmech.2019.02.015openalex-snapshot
Revealing quinquennial anticancer journey of morpholine: A SAR based review
inferred← citeshttps://doi.org/10.1016/j.ejmech.2024.117173openalex-snapshot
Discovery of pyridine-based derivatives as FLT3 inhibitors for the treatment of acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.ejmech.2025.117492openalex-snapshot
Design, synthesis, and biological evaluation of 4-(2-fluorophenoxy)pyridine derivatives as novel FLT3-ITD inhibitors
inferred← citeshttps://doi.org/10.1016/j.jmgm.2019.01.011openalex-snapshot
Discovery of novel Flt3 inhibitory chemotypes through extensive ligand-based and new structure-based pharmacophore modelling methods
inferred← citeshttps://doi.org/10.1016/j.molstruc.2021.131862openalex-snapshot
Identification of 1,3-thiazinan-4-one urea-based derivatives as potent FLT3/VEGFR2 dual inhibitors for the treatment of acute myeloid leukemia
inferred← citeshttps://doi.org/10.1016/j.molstruc.2025.142162openalex-snapshot
Design and synthesis of 1-methyl-2-oxoindolin-3-ylidene-thiazolidine-2,4‑dione-pyrazole hybrids as VEGFR-2 targeting anti-proliferative agents
inferred← citeshttps://doi.org/10.1016/j.rechem.2024.101372openalex-snapshot
Styryl carbamate backbones for the discovery of TME-disrupting agents
inferred← citeshttps://doi.org/10.1021/acs.inorgchem.6b00824openalex-snapshot
Imaging Nuclei of MDA-MB-231 Breast Cancer Cells by Chiral Ruthenium(II) Complex Coordinated by 2-(4-Phenyacetylenephenyl)-1H-imidazo[4,5f][1,10]phenanthroline
inferred← citeshttps://doi.org/10.1021/acs.jcim.5b00691openalex-snapshot
AutoT&T v.2: An Efficient and Versatile Tool for Lead Structure Generation and Optimization
inferred← citeshttps://doi.org/10.1021/acs.jcim.7b00225openalex-snapshot
IFPTarget: A Customized Virtual Target Identification Method Based on Protein–Ligand Interaction Fingerprinting Analyses
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c01511openalex-snapshot
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b00604openalex-snapshot
Drug Discovery against Psoriasis: Identification of a New Potent FMS-like Tyrosine Kinase 3 (FLT3) Inhibitor, 1-(4-((1H-Pyrazolo[3,4-d]pyrimidin-4-yl)oxy)-3-fluorophenyl)-3-(5-(tert-butyl)isoxazol-3-yl)urea, That Showed Potent Activity in a Psoriatic Animal Model
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6c01213openalex-snapshot
Discovery of [(3-Phenylphenyl)carbamoylamino]benzenesulfonyl Fluoride (RTICBM-303), a Cannabinoid Receptor Type 1 Allosteric Modulator that Suppresses Cue- and Drug-Primed Methamphetamine Seeking in Rats
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b01652openalex-snapshot
Identification of 5-(2,3-Dihydro-1 H -indol-5-yl)-7 H -pyrrolo[2,3- d ]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis Model
inferred← citeshttps://doi.org/10.1021/jm401358bopenalex-snapshot
Structure-Based Optimization of Tyrosine Kinase Inhibitor CLM3. Design, Synthesis, Functional Evaluation, and Molecular Modeling Studies.
inferred← citeshttps://doi.org/10.1038/s41401-018-0057-zopenalex-snapshot
High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds
inferred← citeshttps://doi.org/10.1038/s41419-021-03767-9openalex-snapshot
LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuit
inferred← citeshttps://doi.org/10.1038/s41598-022-13515-4openalex-snapshot
Design, synthesis and evaluation of novel tetrahydropyridothienopyrimidin-ureas as cytotoxic and anti-angiogenic agents
inferred← citeshttps://doi.org/10.1038/srep15646openalex-snapshot
SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML
inferred← citeshttps://doi.org/10.1039/c7ob02344hopenalex-snapshot
Structure-based discovery of new maternal embryonic leucine zipper kinase inhibitors
inferred← citeshttps://doi.org/10.1039/c7ra08149aopenalex-snapshot
Synthesis and biological evaluation of 1-(2-(adamantane-1-yl)-1H-indol-5-yl)-3-substituted urea/thiourea derivatives as anticancer agents
inferred← citeshttps://doi.org/10.1039/d1md00125fopenalex-snapshot
Multi-target weapons: diaryl-pyrazoline thiazolidinediones simultaneously targeting VEGFR-2 and HDAC cancer hallmarks
inferred← citeshttps://doi.org/10.1039/d3ra00446eopenalex-snapshot
Design, synthesis, and biological evaluation with molecular dynamics study of novel pyrazolo[3,4- d ]pyrimidine derivatives as anti-cancer agents
inferred← citeshttps://doi.org/10.1039/d3ra02579aopenalex-snapshot
Design, synthesis, and docking studies of novel pyrazole-based scaffolds and their evaluation as VEGFR2 inhibitors in the treatment of prostate cancer
inferred← citeshttps://doi.org/10.1039/d6ra01319hopenalex-snapshot
FLT3 inhibitors in AML: from classic scaffolds to next-generation approaches
inferred← citeshttps://doi.org/10.1080/10426507.2017.1333508openalex-snapshot
Synthesis and herbicidal activity of novel 6-arylthio-3-methylthio-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-ones
inferred← citeshttps://doi.org/10.1080/14756366.2020.1804383openalex-snapshot
Design, synthesis and biological evaluation of a new thieno[2,3- d ]pyrimidine-based urea derivative with potential antitumor activity against tamoxifen sensitive and resistant breast cancer cell lines
inferred← citeshttps://doi.org/10.1089/adt.2014.606openalex-snapshot
A Zebrafish In Vivo Phenotypic Assay to Identify 3-Aminothiophene-2-Carboxylic Acid-Based Angiogenesis Inhibitors
inferred← citeshttps://doi.org/10.1111/cbdd.12484openalex-snapshot
Evaluation of Novel N‐(piperidine‐4‐yl)benzamide Derivatives as Potential Cell Cycle Inhibitors in HepG2 Cells
inferred← citeshttps://doi.org/10.1111/cbdd.12703openalex-snapshot
Discovery of 1,3‐Diaryl‐pyridones as Potent VEGFR ‐2 Inhibitors: Design, Synthesis, and Biological Evaluation
inferred← citeshttps://doi.org/10.1111/cbdd.12808openalex-snapshot
Synthesis, structure–activity relationship studies and biological evaluation of novel 2,5‐disubstituted indole derivatives as anticancer agents
inferred← citeshttps://doi.org/10.1159/000350123openalex-snapshot
SC-535, a Novel Oral Multikinase Inhibitor, Showed Potent Antitumor Activity in Human Melanoma Models
inferred← citeshttps://doi.org/10.18632/oncotarget.9392openalex-snapshot
The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer
inferred← citeshttps://doi.org/10.2174/0109298673277543231205072556openalex-snapshot
Developments of Fms-like Tyrosine Kinase 3 Inhibitors as Anticancer Agents for AML Treatment
inferred← citeshttps://doi.org/10.2174/1573406415666190401144053openalex-snapshot
Design and Synthesis of New Sulfonamides-Based Flt3 Inhibitors
inferred← citeshttps://doi.org/10.3389/fchem.2014.00078openalex-snapshot
Pyrazoles as potential anti-angiogenesis agents: a contemporary overview
inferred← citeshttps://doi.org/10.3390/molecules21060771openalex-snapshot
Discovery of Novel Allopurinol Derivatives with Anticancer Activity and Attenuated Xanthine Oxidase Inhibition
inferred← citeshttps://doi.org/10.3390/molecules22040542openalex-snapshot
Bisarylureas Based on 1H-Pyrazolo[3,4-d]pyrimidine Scaffold as Novel Pan-RAF Inhibitors with Potent Anti-Proliferative Activities: Structure-Based Design, Synthesis, Biological Evaluation and Molecular Modelling Studies
inferred← citeshttps://doi.org/10.3390/molecules30234526openalex-snapshot
Design, Synthesis, Molecular Docking, and Anticancer Activity of Chalcone Derivatives as VEGFR-2 Inhibitors
inferred← citeshttps://doi.org/10.3390/ph15020170openalex-snapshot
In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation
inferred← citeshttps://doi.org/10.4155/fmc-2019-0365openalex-snapshot
Recent Advances in FLT3 Inhibitors for Acute Myeloid Leukemia
inferred← citeshttps://doi.org/10.62110/sciencein.cbl.2024.v11.668openalex-snapshot
Synthesis of new Nilutamide-pyrazole derivatives as VEGFR-2 targeting anti-prostate cancer agents
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.